A programmable hierarchical-responsive nanoCRISPR elicits robust activation of endogenous target to treat cancer.
Theranostics
; 11(20): 9833-9846, 2021.
Article
in En
| MEDLINE
| ID: mdl-34815789
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Genetic Therapy
/
Gene Editing
/
Nanoparticle Drug Delivery System
Limits:
Animals
/
Humans
Language:
En
Journal:
Theranostics
Year:
2021
Document type:
Article
Country of publication:
Australia